| Towards tuberculosis elimination: an action framework for low-incidence countries K Lönnroth, GB Migliori, I Abubakar, L D'Ambrosio, G De Vries, R Diel, ... European Respiratory Journal 45 (4), 928-952, 2015 | 992 | 2015 |
| Hepatitis E virus antibody prevalence among persons who work with swine J Drobeniuc, MO Favorov, CN Shapiro, BP Bell, EE Mast, A Dadu, ... The Journal of infectious diseases 184 (12), 1594-1597, 2001 | 328 | 2001 |
| Multidrug-resistant tuberculosis in Belarus: the size of the problem and associated risk factors A Skrahina, H Hurevich, A Zalutskaya, E Sahalchyk, A Astrauko, S Hoffner, ... Bulletin of the World Health Organization 91, 36-45, 2013 | 279 | 2013 |
| Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project M Zignol, AS Dean, N Alikhanova, S Andres, AM Cabibbe, DM Cirillo, ... The Lancet infectious diseases 16 (10), 1185-1192, 2016 | 233 | 2016 |
| Genetic sequencing for surveillance of drug resistance in tuberculosis in highly endemic countries: a multi-country population-based surveillance study M Zignol, AM Cabibbe, AS Dean, P Glaziou, N Alikhanova, C Ama, ... The Lancet Infectious Diseases 18 (6), 675-683, 2018 | 184 | 2018 |
| Tuberculosis surveillance and monitoring in Europe: 2013. V Hollo, A Dadu, M Dara, K Kremer, MJ Werf, C Ködmön, P Zucs | 112 | 2013 |
| Monitoring therapy adherence of tuberculosis patients by using video-enabled electronic devices A Story, RS Garfein, A Hayward, V Rusovich, A Dadu, V Soltan, ... Emerging infectious diseases 22 (3), 538, 2016 | 108 | 2016 |
| Assessing spatial heterogeneity of multidrug-resistant tuberculosis in a high-burden country HE Jenkins, V Plesca, A Ciobanu, V Crudu, I Galusca, V Soltan, ... European Respiratory Journal 42 (5), 1291-1301, 2013 | 108 | 2013 |
| Factors associated with unfavorable treatment outcomes in new and previously treated TB patients in Uzbekistan: a five year countrywide study J Gadoev, D Asadov, M Tillashaykhov, K Tayler-Smith, P Isaakidis, ... PloS one 10 (6), e0128907, 2015 | 89 | 2015 |
| Drug-resistant tuberculosis in the WHO European Region: an analysis of surveillance data M Zignol, M Dara, AS Dean, D Falzon, A Dadu, K Kremer, H Hoffmann, ... Drug Resistance Updates 16 (6), 108-115, 2013 | 81 | 2013 |
| Multidrug-resistant tuberculosis in Uzbekistan: results of a nationwide survey, 2010 to 2011 DJ Ulmasova, G Uzakova, MN Tillyashayhov, L Turaev, W Van Gemert, ... Euro Surveill 18 (42), 20609, 2013 | 69 | 2013 |
| Video-observed treatment for tuberculosis patients in Belarus: findings from the first programmatic experience H Sinkou, H Hurevich, V Rusovich, L Zhylevich, D Falzon, ... The European respiratory journal 49 (3), 1602049, 2017 | 68 | 2017 |
| Epidemiology of tuberculosis in WHO European Region and public health response M Dara, A Dadu, K Kremer, R Zaleskis, HHP Kluge European Spine Journal 22 (Suppl 4), 549-555, 2013 | 60 | 2013 |
| Drug-resistant tuberculosis in eastern Europe and central Asia: a time-series analysis of routine surveillance data A Dadu, A Hovhannesyan, S Ahmedov, MJ van der Werf, M Dara The Lancet Infectious Diseases 20 (2), 250-258, 2020 | 58 | 2020 |
| Alarming levels of multidrug-resistant tuberculosis in Ukraine: results from the first national survey E Pavlenko, A Barbova, A Hovhannesyan, Z Tsenilova, A Slavuckij, ... The International Journal of Tuberculosis and Lung Disease 22 (2), 197-205, 2018 | 57 | 2018 |
| Drug-resistant tuberculosis in Eastern Europe: challenges and ways forward CD Acosta, A Dadu, A Ramsay, M Dara Public Health Action 4 (2), S3-S12, 2014 | 57 | 2014 |
| Determinants of site of tuberculosis disease: an analysis of European surveillance data from 2003 to 2014 G Sotgiu, D Falzon, V Hollo, C Ködmön, N Lefebvre, A Dadu, ... PloS one 12 (11), e0186499, 2017 | 54 | 2017 |
| Progress toward tuberculosis control and determinants of treatment outcomes—Kazakhstan, 2000–2002 E Bumburidi, S Ajeilat, A Dadu, I Aitmagambetova, J Ershova, R Fagan, ... Morbidity and Mortality Weekly Report 55, S11-S15, 2006 | 34 | 2006 |
| National policies for delivering tuberculosis, HIV and hepatitis B and C virus infection services for refugees and migrants among Member States of the WHO European Region RF Baggaley, J Nazareth, P Divall, D Pan, CA Martin, M Volik, NS Seguy, ... Journal of Travel Medicine 30 (1), taac136, 2023 | 31 | 2023 |
| First national survey of anti-tuberculosis drug resistance in Azerbaijan and risk factors analysis N Alikhanova, I Akhundova, M Seyfaddinova, E Mammadbayov, ... Public Health Action 4 (2), S17-S23, 2014 | 31 | 2014 |
Matteo ZignolUnit Head, Department for HIV, TB, Hepatitis and STIs, World Health OrganizationVerified email at who.int
